In Depth Analysis of Particle Contamination for Inhalable Drug Products
Download our webinar on in depth analysis of particle contamination for inhalable drug products to find the root cause analysis of foreign particulate matter.
The Benefits of Using Raman Spectroscopy and LIBS for Automated Particle Identification
Authors & ContributorsDavid ExlineMarch 26, 2014
Challenges in Counting and Sizing Glass Lamellae using an Automated Method
Glass delamination is a phenomenon which can occur in parenteral drugs stored in glass containers. By interaction of the drug product with the vial surface, the glass surface will sometimes…
Aptar Acquires Nanopharm and Gateway Analytical, Broadening Pharma Services Platform to Accelerate Customer Drug Development
Crystal Lake, Illinois, June 10, 2019 – AptarGroup, Inc. today announced that it has acquired two leading pharmaceutical services companies, Nanopharm Ltd. and Gateway Analytical LLC, for a combined enterprise…
Gateway Analytical Now Offers HIAC Particle Counting and Sizing
New service is available immediately for USP <788> and <789> particulate standards compliance. Pittsburgh, PA (December 5, 2016) – Gateway Analytical, one of the world’s most trusted particle identification and characterization…
Advancing Product Safety Through Cutting-Edge Extractables and Leachables Analysis by Gateway Analytical
In industries where product safety and quality are paramount, the meticulous examination and mitigation of Extractables and Leachables (E&L) risks play a pivotal role. At Gateway Analytical, a leading provider…
2017 RDD Europe: Advancing the Determination of In Vitro Similarity in Tiotropium Formulations for Inhalation
Download our presentation from 2017 RDD Europe on Advancing the Determination of In Vitro Similarity in Tiotropium Formulations for Inhalation.
In-depth characterizations of OINDPs from R&D to regulatory submission
Next Breath and Gateway Analytical will present their OINDP Webinar Series for Dry powder Inhalers (DPIs), pressurized Metered Dose Inhaler (MDIs), and Nasal drug products which are complex delivery systems…
Gateway Analytical Collaborates with the FDA to Present their Latest Findings on Temperature-mediated Drug Agglomerates
PITTSBURGH, March, 11th, 2014 — Gateway Analytical announced today that they have collaborated with researchers from the Division of Pharmaceutical Analysis at the Food and Drug Administration’s Drug Evaluation and Research…
- Go to the previous page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- …
- 12
- Go to the next page